Healthcare Dec 12, 2021 05:48 PM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 12 - Watson biology announced that the company's board meeting considered and passed the proposal. The company's holding subsidiary Yuxi Watson Biotechnology Co., Ltd. (hereinafter referred to as "Yuxi Watson") plans to invest in the production and energy expansion project of polysaccharide conjugate vaccine in Yuxi Watson vaccine Industrial Park, with a total planned investment of about 695 million yuan.
Related companies: